Long non-coding RNAs (lncRNAs) are regulatory transcripts with essential roles in the
pathogenesis of almost all types of cancers, including prostate cancer. They can act as …

Despite advancements, prostate cancers (PCa) are a significant global health due to
delayed diagnosis and therapeutic resistance. This review delves into the complex …

Prostate cancer is the most common cancer in men and the second leading cause of cancer-
related deaths. The most used biomarker to detect prostate cancer is Prostate Specific …

Prostate cancer is the most common type of cancer and frequent cause of cancer-related
mortality in men worldwide. Despite its commonness, the underlying molecular mechanism …

In the entire world, prostate cancer (PCa) is one of the most common and deadly cancers.
Treatment failure is still common among patients, despite PCa diagnosis and treatment …

Prostate cancer (PCa) is considered to be a form of malignancy diagnosed frequently and
ranks sixth in instigating death due to cancer in the male population on a global level. Long …

Prostate cancer is the second most common cause of cancer mortality among men in the
United States. While many prostate cancers are indolent, an important subset of patients …

The importance of long non-coding RNAs (lncRNAs) in the pathogenesis of various
malignancies has been uncovered over the last few years. Their dysregulation often …

Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Recent
advances in the non-protein coding part of human genome analysis have discovered …

Prostate cancer (PCa) is a major health issue in the Western world. Current clinical
imperatives for this disease include better stratification of indolent versus aggressive …